Course: Communicating, Educating, and Triage for Patients Receiving Bispecific Antibodies in RRMM
CME Credits: 1.00
Released: 2026-06-26
This on-demand activity is designed to equip advanced practice providers and oncology nurses with practical strategies to communicate, educate, and triage patients receiving bispecific antibodies for relapsed/refractory multiple myeloma (RRMM). Through expert guidance, learners will strengthen their ability to explain bispecific therapies in clear, patient-centered language, facilitate shared decision-making, and recognize early signs of treatment-related toxicities. The program emphasizes real-world tools and streamlined triage approaches that support patient safety, adherence, and timely intervention across community oncology settings.
Upon completion of this activity, participants should be better able to:
View Full Course